{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:43Z","timestamp":1792801663296,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.parkreldis.2004.06.004","type":"journal-article","created":{"date-parts":[[2004,9,17]],"date-time":"2004-09-17T15:08:02Z","timestamp":1095433682000},"page":"465-468","source":"Crossref","is-referenced-by-count":53,"title":["Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence"],"prefix":"10.1016","volume":"10","author":[{"given":"Mohammad Taghi","family":"Joghataie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Negahdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2004.06.004_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib3","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00002512-200118110-00001","article-title":"Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease","volume":"18","author":"Ross","year":"2001","journal-title":"Drugs Aging"},{"issue":"RC143","key":"10.1016\/j.parkreldis.2004.06.004_bib5","first-page":"1","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.0022-3042.2001.00694.x","article-title":"Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease","volume":"80","author":"Ikeda","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.58.8.1154","article-title":"Caffeinated clues and the promise of adenosine A(2A) antagonists in PD","volume":"58","author":"Schwarzschild","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0300-483X(03)00149-5","article-title":"Protection against ionizing radiation by antioxidant nutrients and phytochemicals","volume":"189","author":"Weiss","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/archneur.1997.00550180070015","article-title":"Dietary antioxidants and Parkinson's disease","volume":"54","author":"De Rijk","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(95)00029-1","article-title":"Oxidative stress and antioxidant therapy in Parkinson's disease","volume":"48","author":"Ebadi","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0301-0082(02)00155-7","article-title":"Adenosine receptors in the nervous system: pathophysiological implications","volume":"68","author":"Ribeiro","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib13","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-8993(00)03296-0","article-title":"Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence","volume":"892","author":"Roghani","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0169-328X(96)00018-6","article-title":"Expression of dopamine transporter mRNA and its binding site in fetal nigral cells transplanted into the striatum of 6-OHDA lesioned rat","volume":"39","author":"Fujita","year":"1996","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0306-4522(92)90447-A","article-title":"Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons","volume":"50","author":"Burke","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/exnr.1994.1058","article-title":"Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57\/b1 and CD-1 mice","volume":"126","author":"Muthane","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research: analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","volume":"67","author":"Przedborski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0006-8993(91)90170-Z","article-title":"Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections","volume":"554","author":"Schwarting","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90576-9","article-title":"Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats","volume":"626","author":"Hudson","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0005-2736(96)00040-5","article-title":"Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species","volume":"1282","author":"Devasagayam","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.parkreldis.2004.06.004_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0009-8981(00)00201-1","article-title":"Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation","volume":"295","author":"Lee","year":"2000","journal-title":"Clin Chim Acta"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380200400118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380200400118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T20:53:41Z","timestamp":1549227221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380200400118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S135380200400118X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2004.06.004","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}